These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12722341)

  • 21. Congenital alpha(2)-plasmin inhibitor deficiencies: a review.
    Favier R; Aoki N; de Moerloose P
    Br J Haematol; 2001 Jul; 114(1):4-10. PubMed ID: 11472338
    [No Abstract]   [Full Text] [Related]  

  • 22. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM; Kalnoski MH; Frederick M; Chandler WL
    Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A splicing donor site point mutation in intron 6 of the plasmin inhibitor (alpha2 antiplasmin) gene with heterozygous deficiency and a bleeding tendency.
    Hanss MM; Farcis M; Ffrench PO; de Mazancourt P; Dechavanne M
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):107-11. PubMed ID: 12544738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha 2-plasmin inhibitor and its deficiency states.
    Saito H
    J Lab Clin Med; 1988 Dec; 112(6):671-8. PubMed ID: 3057093
    [No Abstract]   [Full Text] [Related]  

  • 25. Intracellular transport-deficient mutants causing hereditary deficiencies of factors involved in coagulation and fibrinolysis.
    Miura O; Sugahara Y; Aoki N
    Thromb Haemost; 1993 Mar; 69(3):296-7. PubMed ID: 8470055
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiplasmin: the forgotten serpin?
    Coughlin PB
    FEBS J; 2005 Oct; 272(19):4852-7. PubMed ID: 16176259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
    Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
    J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of alpha2-antiplasmin inhibits E-cadherin processing mediated by the plasminogen activator/plasmin system, leading to suppression of progression of oral squamous cell carcinoma via upregulation of cell-cell adhesion.
    Hayashido Y; Hamana T; Ishida Y; Shintani T; Koizumi K; Okamoto T
    Oncol Rep; 2007 Feb; 17(2):417-23. PubMed ID: 17203182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanisms of impaired secretion in patients with the deficiency of alpha 2-plasmin inhibitor].
    Hirosawa S
    Rinsho Byori; 1997 Feb; Suppl 104():195-202. PubMed ID: 9128382
    [No Abstract]   [Full Text] [Related]  

  • 30. Stachybotrydial selectively enhances fibrin binding and activation of Glu-plasminogen.
    Sasaoka M; Wada Y; Hasumi K
    J Antibiot (Tokyo); 2007 Nov; 60(11):674-81. PubMed ID: 18057696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel allele variant of the SERPINF2 gene responsible for severe plasmin inhibitor (α
    Viganò S; D'Andrea G; Valle PD; Santacroce R; Margaglione M; D'Angelo A
    Thromb Res; 2018 Jun; 166():60-62. PubMed ID: 29656168
    [No Abstract]   [Full Text] [Related]  

  • 32. Lack of alpha 2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice.
    Matsuno H; Ishisaki A; Nakajima K; Okada K; Ueshima S; Matsuo O; Kozawa O
    Blood; 2003 Nov; 102(10):3621-8. PubMed ID: 12893771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemostatic management of intraoral bleeding in patients with congenital deficiency of alpha2-plasmin inhibitor or plasminogen activator inhibitor-1.
    Morimoto Y; Yoshioka A; Imai Y; Takahashi Y; Minowa H; Kirita T
    Haemophilia; 2004 Sep; 10(5):669-74. PubMed ID: 15357795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staplabin, a novel fungal triprenyl phenol which stimulates the binding of plasminogen to fibrin and U937 cells.
    Shinohara C; Hasumi K; Hatsumi W; Endo A
    J Antibiot (Tokyo); 1996 Oct; 49(10):961-6. PubMed ID: 8968387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute myocardial ischemia in a patient with heterozygous alpha-2-plasmin inhibitor deficiency.
    Brands-Nijenhuis AV; van Geel PP; Meijer K
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):599-600. PubMed ID: 19593116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Operative treatment of intramedullary hematoma associated with congenital deficiency of alpha 2-plasmin inhibitor, A report of three cases.
    Miyauchi Y; Mii Y; Aoki M; Tamai S; Takahashi Y; Yoshioka A
    J Bone Joint Surg Am; 1996 Sep; 78(9):1409-14. PubMed ID: 8816660
    [No Abstract]   [Full Text] [Related]  

  • 37. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
    Hunt JA; Petteway SR; Scuderi P; Novokhatny V
    Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of alpha 2-plasmin inhibitor ( alpha 2-PI) in a patient with congenital alpha 2-PI deficiency.
    Kamiya T; Takamatsu J; Koie K; Kohakura M
    Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1513-9. PubMed ID: 7342653
    [No Abstract]   [Full Text] [Related]  

  • 39. Dialysis for a patient who had congenital deficiency of alpha 2-plasmin inhibitor.
    Tatematsu M; Higa A; Sunagawa H; Ikehara O; Shiohira Y
    Clin Nephrol; 1998 May; 49(5):335-6. PubMed ID: 9617504
    [No Abstract]   [Full Text] [Related]  

  • 40. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.